respiratory
Neuromuscular Disease

Antioxidant slows respiratory decline in Duchenne’s: Lancet


A drug initially developed to treat Alzheimer's Disease may be a promising option for patients with Duchenne muscular dystrophy, a small phase III study in The Lancet suggests.  The placebo controlled study of 66 patients with...

A drug initially developed to treat Alzheimer's Disease may be a promising option for patients with Duchenne muscular...

Read more